ArticleAnnals of Ibadan postgraduate medicine2024
OBESITY & HYPERTENSION - 'TWO PEAS IN A POD'.
Article in Annals of Ibadan postgraduate medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a global epidemic of obesity and hypertension. These two relatively common disorders derive from a basic underlying pathophysiologic abnormality, like 'two peas in a pod' There is a consensus that obesity predicts the future development of hypertension and that the relationship between blood pressure and body weight is linear independent of gender, age, and socioeconomic status. This brief commentary outlines the pathogenetic mechanisms for the obesity-hypertension association. These mechanisms are likely complex, multifactorial, and polygenic with possible roots in early ontogeny. A unifying hypothesis should integrate food intake and excess (resulting in weight gain) with increased sympathetic nervous activity (resulting in increased blood pressure). The adipokine, leptin, appears well suited to fill that role - its hypothalamic signaling pathways and neurovascular outcomes are therefore explored in some detail. An understanding of these relationships from the perspectives of both epidemiology and pathophysiology is crucial to the management of both disorders - obesity with hypertension - and particularly more so in developing countries that lack the resources to deal with the looming epidemic of atherosclerotic cardiovascular disease.
Indexed as
Identifiers
40007721PMC11848363What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.